• 한국임상수의학회지
• /
• 제28권3호
• /
• pp.318-322
• /
• 2011

심한 낙상으로 척수 손상을 입은 개 3 마리가 전북대학교 동물의료센터에 내원을 하였다. 내원을 할 당시 환자는 심부통, 정상적 배변 배뇨 반사가 관찰되지 않았다. 신체 검사, 신경계 검사, 컴퓨터 단층 촬영을 실시한 결과, 흉추의 아탈구와 골절로 진단 되었다. 각각의 증례는 등쪽 척추 후궁 절제술과 척추 고정술을 뼈 시멘트와 스테인만 핀을 이용하여 실시 하였다. 술 후 처치는 약 2 주간 실시하였지만 세 증례에서 신경 증상의 개선이 지연되어 나타났다. 전침과 독활기생탕을 이용하여 환자를 치료하였다. 전침 자극과 독활기생탕 투여 14~45일 후에 세 증례에서 운동성, 고유자세반응, 척추 자세 등이 개선되었으며 심부통이 회복되고 꼬리를 흔들었다. 특히 세 마리 중 두 마리는 거의 정상적인 보행과 배변 배뇨 반사를 나타냈지만 뼈 시멘트로 인한 술부의 염증으로 인하여 치료를 중간에 지연한 1 예에서 경과가 좋지 않았다. 이 증례를 바탕으로 술 후 2 주 이후에도 신경 증상의 개선이 없는 환자에서 전침과 독활기생탕의 적용은 환자의 상태를 개선시킬 수 있는 적당한 치료라 생각된다.

• Radiation Oncology Journal
• /
• 제34권4호
• /
• pp.265-272
• /
• 2016

Purpose: The purpose of this study is to evaluate the treatment outcomes of adjuvant radiotherapy using vaginal brachytherapy (VB) with a lower dose per fraction and/or external beam radiotherapy (EBRT) following surgery for patients with stage I endometrial carcinoma. Materials and Methods: The subjects were 43 patients with the International Federation of Gynecology and Obstetrics (FIGO) stage I endometrial cancer who underwent adjuvant radiotherapy following surgery between March 2000 and April 2014. Of these, 25 received postoperative VB alone, while 18 received postoperative EBRT to the whole pelvis; 3 of these were treated with EBRT plus VB. The median EBRT dose was 50.0 Gy (45.0-50.4 Gy) and the VB dose was 24 Gy in 6 fractions. Tumor dose was prescribed at a depth of 5 mm from the cylinder surface and delivered twice per week. Results: The median follow-up period for all patients was 57 months (range, 9 to 188 months). Five-year disease-free survival (DFS) and overall survival (OS) for all patients were 92.5% and 95.3%, respectively. Adjuvant radiotherapy was performed according to risk factors and stage IB, grade 3 and lymphovascular invasion were observed more frequently in the EBRT group. Five-year DFS for EBRT and VB alone were 88.1% and 96.0%, respectively (p = 0.42), and 5-year OS for EBRT and VB alone were 94.4% and 96%, respectively (p = 0.38). There was no locoregional recurrence in any patient. Two patients who received EBRT and 1 patient who received VB alone developed distant metastatic disease. Two patients who received EBRT had severe complications, one each of grade 3 gastrointestinal complication and pelvic bone insufficiency fracture. Conclusion: Adjuvant radiotherapy achieved high DFS and OS with acceptable toxicity in stage I endometrial cancer. VB (with a lower dose per fraction) may be a viable option for selected patients with early-stage endometrial cancer following surgery.